Skip to content
Screenshot-2020-01-22-at-14.21.24
Imaging for the discovery of tomorrow's antivirals
Virus replication NeoVirtech
Virus infection and replication in living cells
image désinfection SARS
Measurement of disinfection efficiency
Technology NeoVirtech
ANCHORTM
Breakthrough tehnology

Services

Next generation technology for virus/viral vector imaging applied in antiviral screening, gene delivery, oncolytic virotherapies and the measurement of disinfection processes

Virology

NeoVirTech has developed a breakthrough technology to directly visualize and quantify in real time virus/viral vector infection and replication in living cells. Application in antiviral discovery and disinfection procedures

Oncolytic virotherapies

Conventional cancer treatments have limited effectiveness in many cases. Oncolytic therapy, based on the use of armed viruses directed against tumor cells, offers new perspectives in the fight against this global scourge.

Drug discovery

Using autofluorescent viruses, we can measure the impact of the presence of a molecule of interest on virus infection and replication capacities.

Disinfection testing

Our technology allows us to quickly calibrate and validate the development of disinfection devices

Imaging

We can offer different types of imaging and also image analysis whether in a viral or non-viral context, from high content imaging to high resolution imaging and light sheet microscopy.

News

New article published in Nature Microbiology on the use of Tecovirimat against MPXV
Tecovirimat is efficient against the 2022 MPXV strain circulating in Europe Delighted to see our work on the efficiency of Tecovirimat on the European Monkeypox...
Picture of the month, October 2022
Picture of the month, October 2022 SARS-CoV-2 infecting human pulmonary cells 48h post-infection, nuclei in blue, SARS-CoV-2 RNA in green, SARS-CoV-2 NP in red. Work...
Picture of the month, September 2022
Picture of the month, September 2022 Orthopoxvirus titration using high resolution imaging. Cells are infected with serial dilution of VACV and stained with crystal violet....
New article published in Nature Microbiology on the use of Tecovirimat against MPXV
Tecovirimat is efficient against the 2022 MPXV strain circulating in Europe Delighted to see our work on the efficiency of...
Picture of the month, October 2022
Picture of the month, October 2022 SARS-CoV-2 infecting human pulmonary cells 48h post-infection, nuclei in blue, SARS-CoV-2 RNA in green,...

Assets

0
Patents
0
Viruses available
0
Worldwide customers
3000
Million parameters measured

BSL2 & BSL3 Lab

Performing the best virology services in BSLII and BSLIII environnement

A word from Franck, our CEO

Having the ability to directly visualize virus infection and replication in living cells using a breakthrough technology with minimum hands-on investment. This is what we propose at NeoVirTech. Our state of the art imaging and screening platform provides a rapid and powerful pipeline to discover compounds that will impact infection capacities and measure disinfection procedures on a large collection of viruses in the human and veterinary market.  As our technology is image-based, the beauty and quality of the data generated is a tremendous asset to boost your research and expand your communication processes.

Partners